Carol Giltner Gallagher, Director at Atara Biotherapeutics, Inc. (ATRA), sold 2,500 shares at $44.68 ($112K) on 2018-06-18, disclosed to the SEC on 2018-06-19.
Open-market sale of $112k ATRA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.68 | 2,100 | $94K | 83.8% |
| 2 | $45.29 | 400 | $18K | 16.2% |
| Total | $44.78 avg | 2,500 | $112K | 100% |
| Filing → |
| ATRA | SELL | 2018-05-16 | $13K | — | Filing → |
| ATRA | SELL | 2018-02-20 | $110K | — | Filing → |
| ATRA | SELL | 2017-11-17 | $17K | — | Filing → |